FDA
Narrative intelligence for FDA: 16 tracked articles, claims, and spin patterns across AI and technology coverage.
Related Articles
FDA asks for feedback on AI medical device regulation - Healio
The U.S. Food and Drug Administration (FDA) issued a formal request for public input on how to regulate artificial intelligence–enabled medical devices, signaling an early-stage policy development effort with implications for safety, innovation pace, and market access.
Aug 22, 2026
Why does it seem like food recalls are out of control this year?
Multiple high-profile food recalls occurred in quick succession across major US brands and retailers, raising public concern about food safety system reliability.
Aug 21, 2026
Radiology Partners petitions FDA for greater clarity around imaging AI regulations - Radiology Business
Radiology Partners, a large U.S. radiology practice management group, formally requested that the FDA provide clearer regulatory guidance for AI tools used in medical imaging — highlighting uncertainty as a barrier to clinical adoption and patient access.
Aug 20, 2026
Trump Taps Dr. Heidi Overton to Lead FDA - WSJ
Donald Trump nominated Dr. Heidi Overton to serve as Commissioner of the U.S. Food and Drug Administration, a regulatory appointment with implications for AI-enabled medical devices, drug approval pathways, and health-tech oversight.
Aug 19, 2026
We finally have Alzheimer’s breakthroughs. Why is Washington holding them back? - Washington Examiner
The article asserts that effective Alzheimer’s treatments now exist but are being delayed by U.S. regulatory processes, framing FDA oversight as the primary obstacle to patient access.
Aug 17, 2026
The FDA changes the rules — rare disease patients pay with their lives - washingtonexaminer.com
The article asserts that recent FDA rule changes are causing rare disease patients to die, but provides no specific details about which rules changed, when, or how they directly cause mortality.
Published Aug 12, 2026 · Analyzed Aug 16, 2026
Food Companies Dodge Crackdown in RFK Jr.’s Proposal on New Additives - WSJ
The article reports that food companies avoided regulatory restrictions under Robert F. Kennedy Jr.'s proposed FDA policy on new food additives, positioning the outcome as a win for industry amid regulatory uncertainty.
Aug 12, 2026
FDA Orders Food-Ingredient Disclosure, Delays RFK Jr.’s Ultraprocessed Crackdown - WSJ
The FDA mandated ingredient disclosure for food products while postponing a proposed crackdown on ultraprocessed foods championed by RFK Jr., reflecting regulatory prioritization and procedural timing rather than policy reversal.
Aug 12, 2026
Doctors and researchers worry that FDA-related wagers on Kalshi and Polymarket could compromise drug development tests and erode public trust in the process (Rebecca Robbins/New York Times)
Medical professionals and researchers express concern that prediction markets like Kalshi and Polymarket—where users bet on FDA regulatory decisions—are creating perverse incentives that could distort clinical trial design, influence drug development priorities, and undermine public confidence in the FDA approval process.
Jul 29, 2026
How the FDA Built an AI Platform That 85% of Its Staff Now Use Daily
Databricks published a blog post highlighting the FDA's adoption of its platform, claiming 85% of FDA staff now use it daily — presented as validation of Databricks’ enterprise AI/data infrastructure value proposition.
Published Jul 23, 2026 · Analyzed Jul 26, 2026
The Great Peptide Cash Grab Has Begun
The FDA may soon relax regulatory oversight of peptide production, triggering speculative commercial interest among telehealth companies anticipating new revenue streams.
Jul 21, 2026
Investors bet on AI drug discovery despite approval gap - Financial Times
Venture capital and institutional investors are pouring billions into AI-driven drug discovery startups even though no AI-designed molecule has yet received full regulatory approval for human use.
Jul 21, 2026
Trust in the FDA is collapsing. It’s time to get really transparent about our food and our drugs - Fortune
The article asserts that public trust in the FDA is collapsing and calls for greater transparency in food and drug regulation, positioning this as an urgent societal need.
Jul 15, 2026
FDA digital leader hints at coming AI policy updates - STAT
The FDA's digital health leadership signaled forthcoming updates to its AI regulatory framework, indicating evolving oversight for AI-driven medical devices and software.
Published Jun 30, 2026 · Analyzed Jul 5, 2026
Unicycive Therapeutics Receives Complete Response Letter - GlobeNewswire
Unicycive Therapeutics received a Complete Response Letter (CRL) from the U.S. FDA regarding its investigational drug application, indicating the agency has identified deficiencies that must be addressed before approval.
Published Jun 30, 2026 · Analyzed Jul 8, 2026
How AI may speed up drug development - Axios
The article reports on speculative potential for AI to accelerate drug development timelines and reduce costs, without citing specific trials, validated models, or regulatory approvals.
Published Jul 16, 2019 · Analyzed Jul 6, 2026
Related Claims
01 Food companies dodged a crackdown in RFK Jr.’s proposal on new additives.
02 The FDA is asking for public feedback on AI medical device regulation.
03 Trust in the FDA is collapsing.
04 No AI-designed drug has received full regulatory approval.
05 Unicycive Therapeutics Receives Complete Response Letter
06 Doctors and researchers worry that FDA-related wagers on Kalshi and Polymarket could compromise drug development tests and erode public trust in the process.
07 Trump Taps Dr. Heidi Overton to Lead FDA
08 FDA ordered food-ingredient disclosure and delayed RFK Jr.’s ultraprocessed crackdown
09 The FDA changes the rules — rare disease patients pay with their lives
10 AI may speed up drug development
11 The FDA recalled more than one million eggs that may be contaminated with salmonella.
12 Radiology Partners petitioned the FDA for greater clarity around imaging AI regulations.
13 FDA digital leader hints at coming AI policy updates
14 The FDA could decide whether to loosen rules around peptide production this week.
15 85% of FDA staff now use [Databricks’ platform] daily
Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO